What Is the Best Diet for EGPA and Steroid Side Effects?
At a Glance
There is no special diet proven to control EGPA or lower eosinophil levels. A balanced, lower-sodium eating pattern may support weight, blood sugar, blood pressure, and bone health during steroid treatment, but it should complement—not replace—prescribed medicines and monitoring.
When living with Eosinophilic Granulomatosis with Polyangiitis (EGPA) — a rare autoimmune disease causing inflammation of the blood vessels (vasculitis) — many people wonder if changing what they eat can help control their disease. The short answer is that there is no specific “anti-inflammatory” or elimination diet proven to cure EGPA or directly lower your eosinophil levels.
Current evidence shows that disease control and reducing eosinophils (a type of white blood cell involved in the disease) rely on clinician-directed pharmacologic therapies [1][2]. These treatments are individualized based on disease severity and organ involvement, and they often include systemic corticosteroids (like prednisone) and biologic therapies (like mepolizumab) [3][4]. While food cannot replace these medications, a thoughtful diet is a useful part of managing the healthcare burden and side effects associated with frequent oral corticosteroid use [5].
Important Safety Warning: Never reduce, stop, or change your corticosteroid dose based on dietary improvements. Abruptly stopping corticosteroids can cause severe complications, including a disease flare or life-threatening adrenal insufficiency. Medication changes must always follow your prescribing clinician’s specific taper plan.
Managing Medication Side Effects Through Diet
Because oral corticosteroids are frequently prescribed in real-world EGPA care [5], managing their side effects is a central part of treatment. Diet is supportive care—it cannot prevent or treat steroid-induced side effects in every patient, but it can help manage the risks.
- Weight Management and Blood Sugar: Corticosteroids can increase appetite and alter how your body processes sugar, increasing the risk of weight gain and elevated blood sugar. Choosing a balanced diet that includes fiber-rich vegetables, lean proteins, and whole grains (rather than heavily processed foods and refined sugars) can offer sensible support. However, if you experience rapid weight gain or abnormal glucose levels, this must be medically assessed; some patients will require medication adjustments.
- Limiting Sodium for Blood Pressure: Steroids can cause your body to hold onto sodium and water, potentially leading to swelling (edema) and high blood pressure. Reducing your salt intake can be helpful, but you should explicitly report new or worsening swelling and high blood pressure readings to your care team.
- Protecting Bone Health: Adequate dietary calcium and vitamin D are supportive, but they do not by themselves prevent glucocorticoid-induced osteoporosis (bone thinning from long-term steroid use). A complete bone health plan requires your doctor to conduct an individualized fracture-risk assessment, recommend appropriate bone-density monitoring, and potentially prescribe bone-protective medications. Any high-dose calcium or vitamin D supplementation should be clinician-guided.
Supporting Cardiovascular Health
Cardiovascular care is a critical part of EGPA management because the disease itself can involve the heart, which can sometimes be clinically subtle [6][7]. Active assessment for cardiac involvement—often including a baseline cardiac magnetic resonance imaging (MRI) scan—is recommended for all patients with EGPA [6][7].
While adopting a general heart-healthy eating pattern (such as the Mediterranean diet, which emphasizes vegetables, healthy fats like olive oil, nuts, and lean proteins) is good for overall cardiovascular health, it does not prevent or treat inflammatory cardiac EGPA.
Seek Urgent Medical Help: If you experience new chest pain, fainting, concerning palpitations, new or worsening breathlessness, coughing blood, sudden neurologic symptoms, or unexplained leg swelling, seek immediate medical assessment. These can be signs of serious cardiac or systemic involvement that require urgent evaluation by your EGPA team.
What About Elimination Diets?
Because EGPA commonly presents with asthma and nasal polyps, it can be tempting to try restrictive elimination diets to see if foods are triggering symptoms. However, EGPA is a complex systemic disease, not an isolated food-triggered disorder [1][2].
Unless you have a confirmed food allergy diagnosed by an allergist, restrictive diets are generally not recommended. There are no EGPA-specific quantitative dietary targets for calories, carbohydrates, or sodium [3][5]. Highly restrictive diets without clinical guidance can make it difficult to get the necessary nutrition your body needs. Consider asking your doctor for a referral to a registered dietitian who has experience working with patients on immunosuppressive medications to create a safe, personalized eating plan that accounts for any other conditions you may have, such as kidney disease or diabetes. Food safety is also important when taking immunosuppressive treatments; ask your care team if you should avoid raw, undercooked, or unpasteurized foods.
Common questions in this guide
Can a special diet control or cure EGPA?
What foods are helpful while I take steroids for EGPA?
Can a Mediterranean diet help with EGPA?
Should I try an elimination diet for EGPA?
How can I protect my bones while taking steroids for EGPA?
Which symptoms of EGPA need immediate medical attention?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my current steroid dose and treatment plan, how often should we monitor my blood sugar, blood pressure, and bone density?
- 2.Have we completed a baseline cardiac assessment, such as a cardiac MRI, to check for any heart involvement from my EGPA?
- 3.Should I consult with a registered dietitian to help manage my nutrition, especially considering my medications and any other health conditions like kidney or metabolic issues?
- 4.What specific symptoms of cardiac involvement or medication side effects should prompt me to contact the office immediately?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (7)
- 1
Eosinophilic Granulomatosis with Polyangiitis: Experiences in Korean Patients.
Choi CB, Park YB, Lee SW
Yonsei medical journal 2019; (60(8)):705-712 doi:10.3349/ymj.2019.60.8.705.
PMID: 31347324 - 2
Genetic and Non-Genetic Contributions to Eosinophilic Granulomatosis with Polyangiitis: Current Knowledge and Future Perspectives.
Treccani M, Veschetti L, Patuzzo C, et al.
Current issues in molecular biology 2024; (46(7)):7516-7529 doi:10.3390/cimb46070446.
PMID: 39057087 - 3
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.
Wechsler ME, Akuthota P, Jayne D, et al.
The New England journal of medicine 2017; (376(20)):1921-1932 doi:10.1056/NEJMoa1702079.
PMID: 28514601 - 4
Real-world safety and effectiveness of mepolizumab for patients with eosinophilic granulomatosis with polyangiitis in Japan: Long-term observation of the MARS study.
Ishii T, Kunishige H, Kobayashi T, et al.
Modern rheumatology 2025; (35(3)):505-515 doi:10.1093/mr/roae100.
PMID: 39508562 - 5
Prevalence, incidence and healthcare burden of eosinophilic granulomatosis with polyangiitis in the UK.
Hwee J, Harper L, Fu Q, et al.
ERJ open research 2024; (10(3)) doi:10.1183/23120541.00430-2023.
PMID: 38746859 - 6
Cardiac Involvement in Eosinophilic Granulomatosis with Polyangiitis.
Srikantharajah M, Gopalan D, Wilson-Morkeh H, et al.
Current cardiology reports 2025; (27(1)):109.
PMID: 40632386 - 7
Cardiac involvement in eosinophilic granulomatosis with polyangiitis: acute eosinophilic myocarditis and chronic inflammatory cardiomyopathy.
Liu X, Zhou Y, Li J, et al.
Rheumatology (Oxford, England) 2025; (64(2)):722-731 doi:10.1093/rheumatology/keae085.
PMID: 38335934
This page is for informational purposes only and explains supportive nutrition for EGPA; it does not replace medical advice or your personalized treatment plan. Never change or stop corticosteroids without instructions from your prescribing clinician.
Get notified when new evidence is published on Eosinophilic granulomatosis with polyangiitis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.